Genscript Biotech Corporation
HKEX:1548.HK
12.1 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 561.371 | 448.218 | 391.311 | 316.109 | 309.589 | 260.528 | 229.568 | 224.452 | 166.394 | 151.476 | 121.878 | 118.796 | 112.221 | 89.263 | 63.386 | 61.535 | 53.2 | 45.659 | 41.05 | 36.473 | 33.521 | 17.499 |
| Cost of Revenue
| 254.385 | 213.713 | 216.263 | 180.524 | 141.091 | 116.629 | 90.949 | 76.732 | 58.221 | 50.085 | 42.979 | 41.623 | 30.855 | 27.606 | 20.452 | 21.203 | 17.303 | 15.439 | 14.192 | 13.728 | 12.168 | 6.474 |
| Gross Profit
| 306.986 | 234.505 | 175.048 | 135.585 | 168.498 | 143.899 | 138.619 | 147.72 | 108.173 | 101.391 | 78.899 | 77.173 | 81.366 | 61.657 | 42.934 | 40.332 | 35.897 | 30.22 | 26.858 | 22.745 | 21.353 | 11.025 |
| Gross Profit Ratio
| 0.547 | 0.523 | 0.447 | 0.429 | 0.544 | 0.552 | 0.604 | 0.658 | 0.65 | 0.669 | 0.647 | 0.65 | 0.725 | 0.691 | 0.677 | 0.655 | 0.675 | 0.662 | 0.654 | 0.624 | 0.637 | 0.63 |
| Reseach & Development Expenses
| 236.384 | 225.496 | 207.331 | 212.49 | 177.606 | 183.271 | 175.13 | 147.95 | 115.451 | 123.186 | 62.836 | 46.208 | 27.868 | 13.271 | 4.784 | 5.919 | 3.548 | 4.67 | 2.439 | 3.073 | 2.516 | 0 |
| General & Administrative Expenses
| 120.173 | 106.926 | 106.515 | 102.814 | 79.648 | 78.195 | 56.313 | 53.976 | 36.365 | 29.09 | 26.166 | 21.397 | 19.185 | 12.66 | 9.379 | 18.372 | 12.057 | 17.21 | 11.325 | 11.811 | 9.635 | 5.362 |
| Selling & Marketing Expenses
| 97.338 | 92.894 | 81.404 | 81.407 | 86.942 | 109.7 | 58.269 | 66.282 | 41.059 | 39.397 | 30.961 | 19.781 | 18.99 | 14.657 | 10.251 | 11.307 | 9.56 | 9.285 | 8.357 | 7.968 | 7.57 | 3.885 |
| SG&A
| 221.374 | 202.231 | 190.286 | 183.838 | 168.125 | 187.592 | 115.813 | 119.614 | 77.424 | 68.487 | 57.127 | 41.178 | 38.175 | 27.317 | 19.63 | 29.679 | 21.617 | 26.495 | 19.682 | 19.779 | 17.205 | 9.246 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.47 | -9.162 | -9.162 |
| Operating Expenses
| 457.758 | 427.727 | 433.153 | 336.38 | 399.342 | 516.354 | 287.701 | 278.358 | 266.022 | 181.027 | 120.522 | 80.884 | 64.907 | 41.915 | 25.143 | 24.123 | 19.863 | 15.175 | 19.175 | 19.991 | 16.153 | 0.084 |
| Operating Income
| -150.772 | -193.222 | -222.569 | -260.743 | -177.233 | -226.964 | -152.324 | -119.844 | -84.702 | -90.282 | -41.064 | -10.213 | 15.323 | 21.069 | 18.52 | 10.653 | 14.28 | 3.725 | 7.176 | 2.966 | 4.148 | 2.062 |
| Operating Income Ratio
| -0.269 | -0.431 | -0.569 | -0.825 | -0.572 | -0.871 | -0.664 | -0.534 | -0.509 | -0.596 | -0.337 | -0.086 | 0.137 | 0.236 | 0.292 | 0.173 | 0.268 | 0.082 | 0.175 | 0.081 | 0.124 | 0.118 |
| Total Other Income Expenses Net
| -54.816 | 86.896 | -22.084 | 58.829 | -52.543 | -140.175 | 2.1 | -4.009 | -73.345 | 13.211 | 4.445 | 13.313 | 4.277 | -0.672 | -0.396 | 5.643 | 1.933 | 11.355 | 0.72 | -0.275 | 0.997 | -0.103 |
| Income Before Tax
| -205.588 | -106.326 | -244.653 | -201.914 | -229.776 | -367.139 | -150.224 | -123.853 | -158.047 | -77.071 | -36.619 | 3.1 | 19.6 | 20.397 | 18.124 | 16.296 | 16.213 | 15.08 | 7.896 | 2.691 | 5.145 | 1.959 |
| Income Before Tax Ratio
| -0.366 | -0.237 | -0.625 | -0.639 | -0.742 | -1.409 | -0.654 | -0.552 | -0.95 | -0.509 | -0.3 | 0.026 | 0.175 | 0.229 | 0.286 | 0.265 | 0.305 | 0.33 | 0.192 | 0.074 | 0.153 | 0.112 |
| Income Tax Expense
| 10.043 | 3.038 | 1.104 | 7.532 | 3.813 | 4.961 | 5.925 | 2.939 | 2.462 | 7.11 | 3.284 | 0.013 | 1.954 | 8.509 | 3.007 | 2.952 | 3.022 | 3.322 | 2.15 | 0.562 | 1.099 | 0.415 |
| Net Income
| -175.115 | -1.896 | -93.581 | -91.344 | -135.507 | -267.59 | -91.122 | -91.853 | -113.092 | -69.566 | -27.346 | 5.697 | 15.519 | 11.143 | 14.98 | 12.979 | 13.191 | 11.758 | 5.746 | 2.129 | 4.046 | 1.544 |
| Net Income Ratio
| -0.312 | -0.004 | -0.239 | -0.289 | -0.438 | -1.027 | -0.397 | -0.409 | -0.68 | -0.459 | -0.224 | 0.048 | 0.138 | 0.125 | 0.236 | 0.211 | 0.248 | 0.258 | 0.14 | 0.058 | 0.121 | 0.088 |
| EPS
| -0.083 | -0.001 | -0.044 | -0.044 | -0.065 | -0.13 | -0.046 | -0.048 | -0.06 | -0.037 | -0.015 | 0.003 | 0.009 | 0.007 | 0.009 | 0.008 | 0.008 | 0.01 | 0.005 | 0.002 | 0.003 | 0.001 |
| EPS Diluted
| -0.083 | -0.001 | -0.044 | -0.043 | -0.065 | -0.13 | -0.046 | -0.048 | -0.06 | -0.037 | -0.015 | 0.003 | 0.009 | 0.007 | 0.009 | 0.008 | 0.008 | 0.01 | 0.005 | 0.002 | 0.003 | 0.001 |
| EBITDA
| -117.937 | -164.282 | -194.236 | -236.132 | -152.765 | -209.453 | -132.116 | -102.646 | -72.062 | -79.598 | -32.764 | -3.56 | 21.004 | 24.657 | 21.547 | 13.2 | 16.775 | 5.941 | 9.645 | 5.308 | 6.509 | 3.287 |
| EBITDA Ratio
| -0.21 | -0.367 | -0.496 | -0.747 | -0.493 | -0.804 | -0.575 | -0.457 | -0.433 | -0.525 | -0.269 | -0.03 | 0.187 | 0.276 | 0.34 | 0.215 | 0.315 | 0.13 | 0.235 | 0.146 | 0.194 | 0.188 |